Institute for International Research

IBC's Antibody Production and Development, the anchor conference of Biopharmaceutical Development & Production Week which took place March 1-5, 2010, continued its long standing tradition of being the most comprehensive event in the industry. Directors, department heads, managers, scientists and engineers from top biopharmaceutical companies gathered in Carlsbad, CA to hear and discuss the challenges, opportunities and developments in the industry.

Conference highlights included:

• Keynote presentations by G. Steven Burrill of Burrill & Company and Dana Andersen, Ph.D., of Genentech, Inc. discussed how the current economic climate is affecting the biotech industry as well as the impact of industrialization of mAb production.
• 40+ presenters shared strategies for developing the latest molecular assessment approaches to optimize manufacturability and product quality and how they are applying smarter and faster tools for rapid process development.
• Companies shared results of mock filings with the FDA and EMEA that explored the impact of Quality by Design and Design of Experiments on process development.
• Five strategic discussion forums facilitated engaging dialogue about new technologies, outsourcing, and whether the biopharma industry would make better progress working together as a community rather than as individual companies.

The sold out exhibit hall which continues to grow year after year, had 80+ exhibitors and provided the perfect venue for attendees and exhibitors to network in a casual no-pressure setting.

Planning is now underway for Biopharmaceutical Development & Production week 2011 which will head to the Hyatt Regency in Bellevue, Washington on March 16-18. Join the Antibody Development & Production [priority contact list] for latest updates on this conference for 2011!

"IBC continues to put together a well organized series of conferences that cover the key topics and areas of interest across the biotech industry. They provide an excellent forum to bring together leading scientists and companies to exchange ideas and create networking contacts."
- William D. Taylor, Director, Business Development, Pfenex

We have conveniently co-located and concurrently scheduled IBC's Outsourcing Manufacturing of Biopharmaceuticals, Technology Transfer of Biopharmaceuticals and Process & Product Validation conferences on March 14-15, 2011. These conferences are scheduled just prior to IBC's Antibody Development & Production and Recombinant Protein & Complex Biologic Development & Production conferences on March 16-18. We offer significant discounts for attending the entire event and encourage attendees to take advantage of the 5 DAY ALL ACCESS PASS. For complete details visit www.IBClifesciences.com/BDPWeek.